As interventional procedures become more complex, one of the biggest issues is the ability of operators to see the devices they are using in the soft tissue anatomy that is mostly invisible under 2-D fluoroscopy. Several companies have developed new navigation aids, including multimodality fusion imaging software from Philips, GE and Siemens. This image shows a new system being developed by Centerline Biomedical. There is a more detailed image below.
Feature | Cath Lab Navigation Aids | Vikash Goel

When Andreas Grüntzig, father of percutaneous transluminal coronary angioplasty, approached his cardiac surgeon ...

Home May 02, 2019
Home
This is the AHA pediatric tachycardia PALS algorithm flow sheet.
Feature | Cardiovascular Education | Judy Haluka, RCIS, EMT

The treatment of all patients in distress with significant symptoms begins with the basics, and pediatric tachycardia is ...

Home May 02, 2019
Home
A comparison of the first photo of a black hole (left) and a nuclear myocardial perfusion exam. This imaging is also referred to as nuclear cardiology, molecular imaging, nuclear heart scan, PET, SPECT cardiac exam.
Feature | Dave Fornell, Editor, and A.J. Connell

May 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home May 01, 2019
Home
Videos | Cath Lab Navigation Aids

Alex Haak, Ph.D., clinical scientist at Philips Health Systems North America, is based at the University of Colorado ...

Home May 01, 2019
Home
Technology | EP Device Monitoring Systems

Digital healthcare company Murj announced the immediate availability of the Murj 2.0 implantable cardiac device management software.

Home May 01, 2019
Home
Technology | Antiplatelet and Anticoagulation Therapies

PhaseBio Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for PB2452, a novel reversal agent for the antiplatelet drug ticagrelor.

Home April 30, 2019
Home
News | Cardiovascular Ultrasound

A new document compiled by four cardiac imaging professional societies provides a resource to guide clinicians in best practices for assessing valvular regurgitation following catheter-based repair or replacement of a valve. The document, available in full here, supplements the previously published guideline Recommendations for Evaluation of Prosthetic Valves with Echocardiography and Doppler Ultrasound.

Home April 30, 2019
Home
News | Cardiovascular Business

New medical technology offers the promise of improving patient care, as well as the potential for harm if caregivers are not sufficiently educated about its operation and use. Without a comprehensive approach, caregivers may learn how to use complex technology at the patient’s bedside, through trial and error, instruction manuals or informally from their colleagues. An article in AACN Advanced Critical Care describes how Memorial Hermann Health System in Houston developed an interdisciplinary fail-safe process to analyze and scale training for use of medical devices, with a risk assessment tool to predict the severity and frequency of potential harm to patients.

Home April 29, 2019
Home
The Aortic intra-aortic axial flow pump is designed to unload the heart and increase renal perfusion in heart failure patients experiencing cardiorenal syndrome.
Feature | Heart Failure | Will Clifton, M.D.

The heart and kidneys are inextricably linked through a diverse web of hemodynamic, neural and hormonal mechanisms. As ...

Home April 29, 2019
Home
News | Cardiac Resynchronization Therapy Devices (CRT)

Biotronik announced the full commercial launch of the Acticor device family, including Acticor DX and CRT-DX devices. Electrophysiologists throughout the United States are now treating patients with the new implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).

Home April 29, 2019
Home
News | Congenital Heart

Edwards Lifesciences is recalling the Miller Balloon Atrioseptostomy Catheter and Fogarty Dilation Atrioseptostomy Catheter because of the possibility of difficulty in balloon deflation after deployment, which may lead to balloon fragmentation or detachment upon attempted retrieval. The firm has received reports of balloon fragmentation or detachment, which may cause serious adverse health consequences including: damage to the heart, the inferior vena cava, and/or the femoral and iliac veins; additional procedures to retrieve the fragments; permanent patient disability; pulmonary embolism; stroke; damage to other organs; or death. One serious injury was reported in which an infant underwent an invasive, but successful surgical procedure to retrieve a detached balloon. There were no deaths reported.

Home April 29, 2019
Home
News | Ultrasound Imaging

With healthcare costs continuing to rise, affordable and accurate imaging and diagnosis achieved through ultrasound will continue to attract patients, according to a new market report from Fact.MR. The report on the global market for ultrasound systems projects steady growth for the market from 2017 to 2022, from a value of $6 billion in 2017 to $7.8 billion toward the end of 2022 — a compound annual growth rate (CAGR) of 5.5 percent.

Home April 26, 2019
Home
Technology | EP Mapping and Imaging Systems

Acutus Medical announced U.S. Food and Drug Administration (FDA) clearance of its second-generation AcQMap platform, along with CE Mark approval for its AcQMap contact mapping software.

Home April 26, 2019
Home
News | Medical 3-D Printing

April 26, 2019 — A 72-year-old woman from northern Michigan became Henry Ford Health System’s 1,000th patient treated ...

Home April 26, 2019
Home
Videos | Structural Heart

Dee Dee Wang, M.D., director of structural heart imaging, Henry Ford Hospital, Detroit, Mich., explains how patient ...

Home April 25, 2019
Home
Subscribe Now